Literature DB >> 31392412

The basis of cellular and regional vulnerability in Alzheimer's disease.

Dunja Mrdjen1, Edward J Fox1, Syed A Bukhari1, Kathleen S Montine1, Sean C Bendall1, Thomas J Montine2.   

Abstract

Alzheimer's disease (AD) differentially and specifically affects brain regions and neuronal cell types in a predictable pattern. Damage to the brain appears to spread and worsens with time, taking over more regions and activating multiple stressors that can converge to promote vulnerability of certain cell types. At the same time, other cell types and brain regions remain intact in the face of this onslaught of neuropathology. Although neuropathologic descriptions of AD have been extensively expanded and mapped over the last several decades, our understanding of the mechanisms underlying how certain regions and cell populations are specifically vulnerable or resistant has lagged behind. In this review, we detail what is known about the selectivity of local initiation of AD pathology in the hippocampus, its proposed spread via synaptic connections, and the diversity of clinical phenotypes and brain atrophy patterns that may arise from different fibrillar strains of pathologic proteins or genetic predispositions. We summarize accumulated and emerging knowledge of the cellular and molecular basis for neuroanatomic selectivity, consider potential disease-relevant differences between vulnerable and resistant neuronal cell types and isolate molecular markers to identify them.

Entities:  

Mesh:

Year:  2019        PMID: 31392412      PMCID: PMC6802290          DOI: 10.1007/s00401-019-02054-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  191 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

Authors:  Sarah K Kaufman; David W Sanders; Talitha L Thomas; Allison J Ruchinskas; Jaime Vaquer-Alicea; Apurwa M Sharma; Timothy M Miller; Marc I Diamond
Journal:  Neuron       Date:  2016-10-27       Impact factor: 17.173

Review 3.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

Review 4.  Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.

Authors:  John H Morrison; Patrick R Hof
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

5.  A post-mortem study of the cholinergic and GABA systems in senile dementia.

Authors:  M N Rossor; N J Garrett; A L Johnson; C Q Mountjoy; M Roth; L L Iversen
Journal:  Brain       Date:  1982-06       Impact factor: 13.501

6.  Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.

Authors:  Walter J Brecht; Faith M Harris; Shengjun Chang; Ina Tesseur; Gui-Qiu Yu; Qin Xu; Jo Dee Fish; Tony Wyss-Coray; Manuel Buttini; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

7.  Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.

Authors:  Ilie-Cosmin Stancu; Bruno Vasconcelos; Laurence Ris; Peng Wang; Agnès Villers; Eve Peeraer; Arjan Buist; Dick Terwel; Peter Baatsen; Tutu Oyelami; Nathalie Pierrot; Cindy Casteels; Guy Bormans; Pascal Kienlen-Campard; Jean-Nöel Octave; Diederik Moechars; Ilse Dewachter
Journal:  Acta Neuropathol       Date:  2015-04-11       Impact factor: 17.088

Review 8.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

9.  Transmissible amyloid protein: evidence from iatrogenic CJD.

Authors:  Mo Hu; Neil P Robertson
Journal:  J Neurol       Date:  2018-07       Impact factor: 4.849

10.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more
  17 in total

Review 1.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

Review 2.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

3.  Extracellular Sortilin Proteopathy Relative to β-Amyloid and Tau in Aged and Alzheimer's Disease Human Brains.

Authors:  Tian Tu; Juan Jiang; Qi-Lei Zhang; Lily Wan; Ya-Nan Li; Aihua Pan; Jim Manavis; Xiao-Xin Yan
Journal:  Front Aging Neurosci       Date:  2020-05-12       Impact factor: 5.750

4.  Differences in Cerebral Structure Associated With Depressive Symptoms in the Elderly With Alzheimer's Disease.

Authors:  Yue Wu; Xingqi Wu; Qiang Wei; Kai Wang; Yanghua Tian
Journal:  Front Aging Neurosci       Date:  2020-05-12       Impact factor: 5.750

Review 5.  The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.

Authors:  Isabel Ubeda-Bañon; Daniel Saiz-Sanchez; Alicia Flores-Cuadrado; Ernesto Rioja-Corroto; Melania Gonzalez-Rodriguez; Sandra Villar-Conde; Veronica Astillero-Lopez; Juan Pablo Cabello-de la Rosa; Maria Jose Gallardo-Alcañiz; Julia Vaamonde-Gamo; Fernanda Relea-Calatayud; Lucia Gonzalez-Lopez; Alicia Mohedano-Moriano; Alberto Rabano; Alino Martinez-Marcos
Journal:  Transl Neurodegener       Date:  2020-06-03       Impact factor: 8.014

6.  Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex.

Authors:  Xiaoyan Sun; Qian Wang; Kaj Blennow; Henrik Zetterberg; Micheline McCarthy; David A Loewenstein; Regina Vontell; Zhenyu Yue; Bin Zhang
Journal:  Alzheimers Dement (N Y)       Date:  2021-04-09

7.  Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology.

Authors:  Sourena Soheili-Nezhad; Robert J van der Linden; Marcel Olde Rikkert; Emma Sprooten; Geert Poelmans
Journal:  Alzheimers Dement       Date:  2020-10-19       Impact factor: 21.566

8.  Baicalein Ameliorates Aβ-Induced Memory Deficits and Neuronal Atrophy via Inhibition of PDE2 and PDE4.

Authors:  Jing Shi; Yuanyuan Li; Yi Zhang; Jie Chen; Jianqing Gao; Tianyuan Zhang; Xiaoguang Shang; Xiangnan Zhang
Journal:  Front Pharmacol       Date:  2021-12-13       Impact factor: 5.810

9.  Neurodegenerative proteinopathies associated with neuroinfections.

Authors:  Krisztina Danics; Shelley L Forrest; Istvan Kapas; Irene Erber; Susanne Schmid; Klára Törő; Katalin Majtenyi; Gabor G Kovacs
Journal:  J Neural Transm (Vienna)       Date:  2021-07-05       Impact factor: 3.575

10.  Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology.

Authors:  Xu Hou; Jens O Watzlawik; Casey Cook; Chia-Chen Liu; Silvia S Kang; Wen-Lang Lin; Michael DeTure; Michael G Heckman; Nancy N Diehl; Fadi S Hanna Al-Shaikh; Ronald L Walton; Owen A Ross; Heather L Melrose; Nilüfer Ertekin-Taner; Guojun Bu; Leonard Petrucelli; John D Fryer; Melissa E Murray; Dennis W Dickson; Fabienne C Fiesel; Wolfdieter Springer
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.